Newgenivf Group Limited (NIVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 4,726 | 5,433 | 5,136 | 5,944 | 0 |
| Cost of Goods | 3,771 | 3,607 | 3,454 | 4,406 | N/A |
| Gross Profit | 956 | 1,827 | 1,682 | 1,538 | N/A |
| Operating Expenses | 12,453 | 3,594 | 2,094 | 1,546 | 0 |
| Operating Income | -10,727 | -1,161 | 42 | 399 | N/A |
| Interest Expense | 616 | 779 | 46 | 78 | 0 |
| Other Income | 21,072 | 978 | 112 | 23 | 0 |
| Pre-tax Income | 9,729 | -961 | 108 | 344 | 0 |
| Income Tax | N/A | -487 | N/A | 208 | N/A |
| Net Income Continuous | 9,729 | -474 | 108 | 136 | N/A |
| Minority Interests | -151 | 51 | -22 | -323 | N/A |
| Net Income | $9,879 | $-525 | $130 | $459 | $N/A |
| EPS Basic Total Ops | 214.73 | -4,408.76 | 10,591.06 | 48,004.79 | N/A |
| EPS Basic Continuous Ops | 211.45 | -3,984.04 | 10,576.02 | 14,154.60 | N/A |
| EPS Diluted Total Ops | 3.04 | -4,408.76 | 10,591.06 | 48,004.79 | N/A |
| EPS Diluted Continuous Ops | 2.99 | -3,984.04 | 10,576.02 | 14,154.60 | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | -1,920.19 | N/A | N/A | N/A |
| EBITDA(a) | $-10,485 | $-1,108 | $73 | $499 | $N/A |